Skip to content

Creatine and GAA for Brain Oxygenation

Enhancing Brain Oxygenation: Effects of Short-Term Co-Administration of Creatine and Guanidinoacetic Acid at Rest and During Stress

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06371651
Acronym
CREGAA-OXY
Enrollment
19
Registered
2024-04-17
Start date
2024-03-01
Completion date
2024-04-12
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Deficiency

Keywords

creatine, guanidinoacetic acid, oxygen saturation, brain

Brief summary

The main aim of this randomized controlled trial is to evaluate cerebral blood oxygenation after 7-day administration of a creatine-guanidinoacetic acid (GAA) mixture in healthy adults before, during, and after a series of cognitive tests.

Interventions

DIETARY_SUPPLEMENTSupplement

Dietary supplement containing creatine and guanidinoacetic acid

DIETARY_SUPPLEMENTPlacebo

Inert substance

Sponsors

University of Novi Sad, Faculty of Sport and Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-30 years * Absence of metabolic disorders or other health complications * Provision of signed informed consent

Exclusion criteria

* History of dietary supplement use within the preceding 4 weeks * Lack of consent to randomization * Concurrent participation in other studies

Design outcomes

Primary

MeasureTime frameDescription
Brain oxygen saturationChange from baseline brain oxygen saturation at 2 weeksPercentage of oxygen saturation in prefrontal brain

Secondary

MeasureTime frameDescription
Hemoglobin indexChange from baseline hemoglobin index at 2 weeksConcentration of hemoglobin index in prefrontal brain

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026